Schrödinger Stock Price, News & Analysis (NASDAQ:SDGR) $31.60 -0.66 (-2.05%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$31.35▼$33.5750-Day Range$21.62▼$32.4952-Week Range$15.85▼$59.24Volume768,341 shsAverage Volume925,723 shsMarket Capitalization$2.28 billionP/E Ratio56.43Dividend YieldN/APrice Target$49.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Schrödinger MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside57.8% Upside$49.86 Price TargetShort InterestBearish9.16% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.29Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom $0.26 to ($1.57) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.06 out of 5 starsMedical Sector727th out of 948 stocksPharmaceutical Preparations Industry329th out of 421 stocks 3.3 Analyst's Opinion Consensus RatingSchrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $49.86, Schrödinger has a forecasted upside of 57.8% from its current price of $31.60.Amount of Analyst CoverageSchrödinger has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted9.16% of the outstanding shares of Schrödinger have been sold short.Short Interest Ratio / Days to CoverSchrödinger has a short interest ratio ("days to cover") of 8.8.Change versus previous monthShort interest in Schrödinger has recently decreased by 4.90%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSchrödinger does not currently pay a dividend.Dividend GrowthSchrödinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SDGR. Previous Next 2.4 News and Social Media Coverage News SentimentSchrödinger has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Schrödinger this week, compared to 2 articles on an average week.Search Interest9 people have searched for SDGR on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days.MarketBeat FollowsOnly 8 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Schrödinger insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.60% of the stock of Schrödinger is held by insiders.Percentage Held by Institutions81.14% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Schrödinger are expected to decrease in the coming year, from $0.26 to ($1.57) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrödinger is 56.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.07.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrödinger is 56.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 130.37.Price to Earnings Growth RatioSchrödinger has a PEG Ratio of 30.18. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSchrödinger has a P/B Ratio of 5.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Schrödinger Stock (NASDAQ:SDGR)Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.Read More SDGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SDGR Stock News HeadlinesDecember 6, 2023 | americanbankingnews.comSchrödinger (NASDAQ:SDGR) Coverage Initiated by Analysts at KeyCorpDecember 5, 2023 | msn.comKeybanc Initiates Coverage of Schrodinger (SDGR) with Overweight RecommendationDecember 6, 2023 | Edge On The Street (Ad)U.S. Military Defense Fails Without Vanadium?The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply. November 6, 2023 | seekingalpha.comSchrodinger: Attractive Risk-RewardNovember 6, 2023 | benzinga.comSchrödinger to Participate in Upcoming Investor ConferencesNovember 2, 2023 | finance.yahoo.comSchrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual MeetingNovember 2, 2023 | finance.yahoo.comIs Schrödinger Stock a Buy Now?November 1, 2023 | finance.yahoo.comSchrodinger Inc (SDGR) Reports Q3 2023 Financial Results: Total Revenue Up by 15.1%December 6, 2023 | Edge On The Street (Ad)U.S. Military Defense Fails Without Vanadium?The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply. November 1, 2023 | markets.businessinsider.comSchrödinger, Inc Q3 Loss Increases, but beats estimatesNovember 1, 2023 | finance.yahoo.comSchrödinger Reports Third Quarter 2023 Financial ResultsOctober 30, 2023 | finance.yahoo.comSDGR Nov 2023 15.000 putOctober 26, 2023 | markets.businessinsider.comHold Rating Maintained for Schrodinger amidst Challenging Market Conditions and Operational StabilityOctober 25, 2023 | finance.yahoo.comThis Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest?September 29, 2023 | seekingalpha.comSchrodinger: Leading The AI Healthcare RevolutionSeptember 28, 2023 | stockhouse.comSchrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling EducationSeptember 16, 2023 | finance.yahoo.comSDGR Sep 2023 45.000 callSeptember 5, 2023 | finance.yahoo.comSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceSeptember 2, 2023 | seekingalpha.comSchrodinger: More Than An AI Bubble StockAugust 16, 2023 | seekingalpha.comSchrodinger: A Computational Platform That Is Likely Becoming ObsoleteAugust 5, 2023 | msn.comMorgan Stanley Reiterates Schrodinger (SDGR) Equal-Weight RecommendationAugust 3, 2023 | marketwatch.comSchrödinger Shares Tumble 22% on 2Q Revenue Decline, Lower 2023 OutlookAugust 3, 2023 | finance.yahoo.comWhy Shares of Schrödinger Are Falling ThursdayAugust 3, 2023 | benzinga.comWhy Is Schrödinger Stock Tumbling Today?August 3, 2023 | technews.tmcnet.comSchrödinger Reports Second Quarter 2023 Financial ResultsAugust 2, 2023 | seekingalpha.comSchrödinger, Inc. 2023 Q2 - Results - Earnings Call PresentationAugust 2, 2023 | msn.comSchrodinger (SDGR) Price Target Increased by 5.40% to 59.73See More Headlines Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/01/2023Today12/06/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SDGR CUSIPN/A CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees800Year FoundedN/APrice Target and Rating Average Stock Price Target$49.86 High Stock Price Target$67.00 Low Stock Price Target$23.00 Potential Upside/Downside+57.8%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$0.56 Trailing P/E Ratio56.43 Forward P/E Ratio121.54 P/E Growth30.18Net Income$-149,190,000.00 Net Margins22.16% Pretax Margin23.61% Return on Equity-24.03% Return on Assets-16.81% Debt Debt-to-Equity RatioN/A Current Ratio5.21 Quick Ratio5.21 Sales & Book Value Annual Sales$180.96 million Price / Sales12.58 Cash FlowN/A Price / Cash FlowN/A Book Value$6.29 per share Price / Book5.02Miscellaneous Outstanding Shares72,030,000Free Float66,558,000Market Cap$2.28 billion OptionableNot Optionable Beta1.58 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Ramy Farid Ph.D. (Age 58)CEO, President & Director Comp: $1.04MDr. Richard A. Friesner Ph.D. (Age 70)Co-Founder, Scientific Advisory Chairman and Director Comp: $455kDr. Geoffrey Craig Porges MBBSExecutive VP & CFODr. Robert Lorne Abel Ph.D. (Age 41)Executive VP of Science, Chief Computational Scientist and Head of Modeling R&D Comp: $528.37kMs. Yvonne Tran Esq. (Age 52)Chief Legal & People Officer Comp: $670.1kDr. Karen Akinsanya Ph.D. (Age 55)President of Research & Development Therapeutics Comp: $777.68kMs. Jenny HermanSenior VP of Finance & Corporate ControllerProf. William Goddard IIICo-Founder & Scientific AdvisorMr. Kenneth Patrick Lorton (Age 39)Executive VP & CTO Comp: $510.09kMr. Shane Brauner (Age 45)Executive VP & Chief Information Officer More ExecutivesKey CompetitorsRocket PharmaceuticalsNASDAQ:RCKTCrinetics PharmaceuticalsNASDAQ:CRNXCymaBay TherapeuticsNASDAQ:CBAYIndiviorNASDAQ:INDVRhythm PharmaceuticalsNASDAQ:RYTMView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Bought 24,578 shares on 11/30/2023Ownership: 0.386%Deutsche Bank AGSold 34,659 shares on 11/24/2023Ownership: 0.190%Public Sector Pension Investment BoardSold 27,764 shares on 11/22/2023Ownership: 0.094%Walleye Trading LLCSold 900 shares on 11/21/2023Ownership: 0.000%Walleye Capital LLCSold 4,800 shares on 11/21/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions SDGR Stock Analysis - Frequently Asked Questions Should I buy or sell Schrödinger stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Schrödinger in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SDGR shares. View SDGR analyst ratings or view top-rated stocks. What is Schrödinger's stock price target for 2024? 6 Wall Street analysts have issued 1 year target prices for Schrödinger's stock. Their SDGR share price targets range from $23.00 to $67.00. On average, they expect the company's stock price to reach $49.86 in the next year. This suggests a possible upside of 57.8% from the stock's current price. View analysts price targets for SDGR or view top-rated stocks among Wall Street analysts. How have SDGR shares performed in 2023? Schrödinger's stock was trading at $18.69 on January 1st, 2023. Since then, SDGR stock has increased by 69.1% and is now trading at $31.60. View the best growth stocks for 2023 here. When is Schrödinger's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our SDGR earnings forecast. How were Schrödinger's earnings last quarter? Schrödinger, Inc. (NASDAQ:SDGR) released its earnings results on Wednesday, November, 1st. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.69) by $0.17. The firm earned $42.57 million during the quarter, compared to analysts' expectations of $39.02 million. Schrödinger had a negative trailing twelve-month return on equity of 24.03% and a net margin of 22.16%. What ETFs hold Schrödinger's stock? ETFs with the largest weight of Schrödinger (NASDAQ:SDGR) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), TrueShares Technology, AI & Deep Learning ETF (LRNZ), Northern Lights Fund Trust IV - Long Cramer Tracker ETF (LJIM), Subversive Mental Health ETF (SANE), Jacob Forward ETF (JFWD), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR FactSet Innovative Technology ETF (XITK) and Motley Fool Small-Cap Growth ETF (TMFS). What guidance has Schrödinger issued on next quarter's earnings? Schrödinger issued an update on its FY 2023 earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $205.94 million-$230.01 million, compared to the consensus revenue estimate of $221.63 million. What is Ramy Farid's approval rating as Schrödinger's CEO? 8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Schrödinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ), Cisco Systems (CSCO), Teladoc Health (TDOC), Alteryx (AYX) and QUALCOMM (QCOM). When did Schrödinger IPO? (SDGR) raised $150 million in an IPO on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO. Who are Schrödinger's major shareholders? Schrödinger's stock is owned by a number of institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (4.10%), ARK Investment Management LLC (3.95%), FMR LLC (2.41%), Morgan Stanley (2.07%), Sumitomo Mitsui Trust Holdings Inc. (2.00%) and Tocqueville Asset Management L.P. (1.01%). Insiders that own company stock include Cony D'cruz, David E Shaw, Gary Sender, Jennifer Daniel, Jenny Herman, Joel Lebowitz, Jorg Weiser, Karen Akinsanya, Kenneth Patrick Lorton, Michael Lynton, Nancy Thornberry, Ramy Farid, Richard Friesner, Robert Lorne Abel, Rosana Kapeller-Libermann, Shane Brauner and Yvonne Tran. View institutional ownership trends. How do I buy shares of Schrödinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:SDGR) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrödinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.